Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 22.1
1.94 %
$ 630 M
Market Cap
35.65
P/E
Price Target
Average
78.73%
Revenue Forecast
Estimate
18.71%
EBIT
Estimate
--8.12%
Net Income
Estimate
56.62%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Castle Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for CSTL of $39.5 , with forecasts ranging from
a
low of
$35 to a high of $45 .
CSTL Lowest Price Target
Wall Street Target
35 USD
58.37%
CSTL Average Price Target
Wall Street Target
39.5 USD
78.73%
CSTL Highest Price Target
Wall Street Target
45 USD
103.62%
REVENUE FORECAST
Revenue Forecast Chart CSTL
EBIT FORECAST
EBIT Forecast Chart CSTL
NET INCOME FORECAST
Net Income Chart CSTL